SCHEMBL4843648

SCHEMBL4843648

COc1ccc2c(c1)/C(=C/C(=O)c1cccc(NC(=O)C(Cl)(Cl)Cl)c1)NC(C)(C)C2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.47
MEN1 O00255 4/20 0.40
LMNA P02545 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPT P10636 4/20 0.39
HTT P42858 2/20 0.39
ALDH1A1 P00352 4/20 0.38
CYP1A2 P05177 3/20 0.38
CYP2D6 P10635 3/20 0.38
CYP2C9 P11712 3/20 0.38
CYP2C19 P33261 3/20 0.38
CYP3A4 P08684 2/20 0.38
HPGD P15428 2/20 0.38
GAA P10253 2/20 0.38
CDYL2 Q8N8U2 1/20 0.38
CDYL Q9Y232 1/20 0.38
CDY1; CDY1B Q9Y6F8 1/20 0.38
NPC1 O15118 5/20 0.38
RAB9A P51151 4/20 0.38
SMN1; SMN2 Q16637 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4843658 1.00 KMT2A (0.47) KMT2AMEN1LMNAKDM4EMAPT
SCHEMBL4844317 0.92 KMT2A (0.43) KMT2AMEN1LMNAKDM4EMAPT
SCHEMBL4844296 0.92 KMT2A (0.43) KMT2AMEN1LMNAKDM4EMAPT
SCHEMBL4842685 0.91 KMT2A (0.41) KMT2AMEN1LMNAKDM4EMAPT
SCHEMBL4842691 0.91 KMT2A (0.41) KMT2AMEN1LMNAKDM4EMAPT
SCHEMBL4839243 0.90 TSHR (0.45) KMT2AMEN1LMNAKDM4EMAPT
SCHEMBL4839226 0.90 TSHR (0.45) KMT2AMEN1LMNAKDM4EMAPT
SCHEMBL4839175 0.90 LMNA (0.42) KMT2AMEN1LMNAKDM4EMAPT
SCHEMBL4839189 0.90 LMNA (0.42) KMT2AMEN1LMNAKDM4EMAPT
SCHEMBL4837826 0.89 ALDH1A1 (0.45) KMT2AMEN1LMNAKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 KMT2A 4642/4885MEN1 1230/4885LMNA 3014/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.